Quest Diagnostics Inc (Q1UE34)
BOV
The current Q1UE34 market cap is 51.33B. The company's latest EPS is USD 7.5955 and P/E is 20.00.
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 2.3B | 2.29B | 2.37B | 2.4B | 2.49B |
Operating Income | 347M | 245M | 300M | 355M | 330M |
Net Income | 225M | 192M | 194M | 229M | 226M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 7.82B | 9.44B | 10.79B | 9.88B | 9.25B |
Operating Income | 1.23B | 1.97B | 2.38B | 1.43B | 1.26B |
Net Income | 858M | 1.43B | 2B | 946M | 854M |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 13.48B | 14.02B | 13.95B | 13.88B | 16.1B |
Total Liabilities | 6.94B | 7.6B | 7.41B | 7.15B | 9.17B |
Total Equity | 6.46B | 6.34B | 6.47B | 6.66B | 6.84B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 12.84B | 14.03B | 13.61B | 12.84B | 14.02B |
Total Liabilities | 7.08B | 7.14B | 7.05B | 6.83B | 7.6B |
Total Equity | 5.69B | 6.81B | 6.48B | 5.93B | 6.34B |
Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 745M | 1.27B | 154M | 514M | 870M |
Investing | -947M | -1.06B | -213M | -413M | -2.05B |
Financing | 30M | 160M | -153M | -516M | 1.25B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 1.24B | 2.01B | 2.23B | 1.72B | 1.27B |
Investing | -411M | -772M | 21M | -543M | -1.06B |
Financing | 225M | -1.27B | -2.54B | -1.73B | 160M |
Market Cap | 51.33B |
Price to Earnings Ratio | 20.00 |
Price to Sales Ratio | 1.85 |
Price to Cash Ratio | 24.9 |
Price to Book Ratio | 2.66 |
Dividend Yield | 1.33% |
Shares Outstanding | 112.44M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | 36.30% |
52 Week High | 456.51 |
52 Week Low | 307.83 |
Spread (Intraday) | 30.82 (6.55%) |
Company Name | Quest Diagnostics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.questdiagnostics.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.